179 related articles for article (PubMed ID: 29742812)
1. Binding of Free and Immune Complex-Associated Hepatitis C Virus to Erythrocytes Is Mediated by the Complement System.
Salam KA; Wang RY; Grandinetti T; De Giorgi V; Alter HJ; Allison RD
Hepatology; 2018 Dec; 68(6):2118-2129. PubMed ID: 29742812
[TBL] [Abstract][Full Text] [Related]
2. Preferential association of hepatitis C virus with CD19
Wang RY; Bare P; De Giorgi V; Matsuura K; Salam KA; Grandinetti T; Schechterly C; Alter HJ
Hepatology; 2016 Dec; 64(6):1900-1910. PubMed ID: 27641977
[TBL] [Abstract][Full Text] [Related]
3. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
Schifferli JA; Ng YC; Paccaud JP; Walport MJ
Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
[TBL] [Abstract][Full Text] [Related]
4. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes.
Nielsen CH; Matthiesen SH; Lyng I; Leslie RG
Immunology; 1997 Jan; 90(1):129-37. PubMed ID: 9038723
[TBL] [Abstract][Full Text] [Related]
5. Erythrocytes from young but not elderly donors can bind and degrade immune complex- and antibody-bound C3 in vitro.
Shapiro S; Kohn D; Miller B; Gershon H
Clin Exp Immunol; 1994 Jan; 95(1):181-90. PubMed ID: 8287603
[TBL] [Abstract][Full Text] [Related]
6. Binding of immune complexes to erythrocyte CR1 (CD35): difference in requirement of classical pathway components and indication of alternative pathway-mediated binding in C2-deficiency.
Klint C; Gullstrand B; Sturfelt G; Truedsson L
Scand J Immunol; 2000 Jul; 52(1):103-8. PubMed ID: 10886790
[TBL] [Abstract][Full Text] [Related]
7. Immune complex-like moieties in immunoglobulin for intravenous use (i.v.Ig) bind complement and enhance phagocytosis of human erythrocytes.
Shoham-Kessary H; Naot Y; Gershon H
Clin Exp Immunol; 1998 Jul; 113(1):77-84. PubMed ID: 9697987
[TBL] [Abstract][Full Text] [Related]
8. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
[TBL] [Abstract][Full Text] [Related]
9. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
Emlen W; Burdick G; Carl V; Lachmann PJ
J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
[TBL] [Abstract][Full Text] [Related]
10. Complement-dependent binding of C-reactive protein complexes to human erythrocyte CR1.
Mold C; Gurulé C; Otero D; Du Clos TW
Clin Immunol Immunopathol; 1996 Nov; 81(2):153-60. PubMed ID: 8906746
[TBL] [Abstract][Full Text] [Related]
11. Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients.
Kanto T; Hayashi N; Takehara T; Katayama K; Kato M; Akiyama M; Kasahara A; Fusamoto H; Kamada T
J Med Virol; 1996 Oct; 50(2):126-34. PubMed ID: 8915878
[TBL] [Abstract][Full Text] [Related]
12. Immune complexes bind preferentially to specific subpopulations of human erythrocytes.
Cosio FG; Shen XP; Hebert LA
Clin Immunol Immunopathol; 1990 Jun; 55(3):337-54. PubMed ID: 2140304
[TBL] [Abstract][Full Text] [Related]
13. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
14. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
Taylor RP; Pocanic F; Reist C; Wright EL
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
[TBL] [Abstract][Full Text] [Related]
15. Complement depletion accelerates the clearance of immune complexes from the circulation of primates.
Waxman FJ; Hebert LA; Cornacoff JB; VanAman ME; Smead WL; Kraut EH; Birmingham DJ; Taguiam JM
J Clin Invest; 1984 Oct; 74(4):1329-40. PubMed ID: 6480828
[TBL] [Abstract][Full Text] [Related]
16. Relationship between immune complex binding and release and the quantitative expression of the complement receptor, type 1 (CR1, CD35) on human erythrocytes.
Gibson NC; Waxman FJ
Clin Immunol Immunopathol; 1994 Feb; 70(2):104-13. PubMed ID: 8299225
[TBL] [Abstract][Full Text] [Related]
17. Exposure to complement-bearing immune complexes enhances the in vitro sequestration of erythrocytes from young but not elderly donors.
Shapiro S; Pilar T; Gershon H
Clin Exp Immunol; 1993 Feb; 91(2):301-7. PubMed ID: 8428395
[TBL] [Abstract][Full Text] [Related]
18. Reduced erythrocyte CR1 (CD 35) receptor function and complement opsonization in factor I-deficient patients is restored by plasma infusion.
Jepsen HH; Teisner B; Rasmussen JM; Svehag SE
Scand J Immunol; 1989 Feb; 29(2):247-55. PubMed ID: 2522236
[TBL] [Abstract][Full Text] [Related]
19. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
[TBL] [Abstract][Full Text] [Related]
20. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
Paccaud JP; Carpentier JL; Schifferli JA
Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
